Search Results

MPEP hydrochloride 50mg 50mg  | Purity Not Available

Adooq Bioscience

MPEP hydrochloride is a potent and highly selective non-competitive antagonist at the mGlu5 receptor subtype (IC50 = 36 nM) and a positive allosteric modulator at mGlu4 receptors.

More Information Supplier Page

MPEP hydrochloride 25mg 25mg  | Purity Not Available

Adooq Bioscience

MPEP hydrochloride is a potent and highly selective non-competitive antagonist at the mGlu5 receptor subtype (IC50 = 36 nM) and a positive allosteric modulator at mGlu4 receptors.

More Information Supplier Page

Cevipabulin (TTI-237) 5mg 5mg  | Purity Not Available

Adooq Bioscience

Cevipabulin (TTI-237), an antimicrotubule agent, is a small synthetic molecule of triazolopyrimidine derivative with potential antitumor activity. With a novel mechanism of action distinct from the action of other vinca alkaloid compounds, TTI-237 specifically binds to tubulin at the vinca site, and promotes the polymerization of tubulin into microtubules.

More Information Supplier Page

Cevipabulin (TTI-237) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Cevipabulin (TTI-237), an antimicrotubule agent, is a small synthetic molecule of triazolopyrimidine derivative with potential antitumor activity. With a novel mechanism of action distinct from the action of other vinca alkaloid compounds, TTI-237 specifically binds to tubulin at the vinca site, and promotes the polymerization of tubulin into microtubules.

More Information Supplier Page

MSX-122 50mg 50mg  | Purity Not Available

Adooq Bioscience

MSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.

More Information Supplier Page

MSX-122 25mg 25mg  | Purity Not Available

Adooq Bioscience

MSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.

More Information Supplier Page

MSX-122 100mg 100mg  | Purity Not Available

Adooq Bioscience

MSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.

More Information Supplier Page

MSX-122 10mg 10mg  | Purity Not Available

Adooq Bioscience

MSX-122 is an orally bioavailable inhibitor of CXCR4 with potential antineoplastic and antiviral activities. CXCR4 inhibitor MSX-122 binds to the chemokine receptor CXCR4, preventing the binding of stromal derived factor-1 (SDF-1) to the CXCR4 receptor and receptor activation, which may result in decreased tumor cell proliferation and migration.

More Information Supplier Page

Ascomycin 5mg 5mg  | Purity Not Available

Adooq Bioscience

Ascomycin is a potent immunosuppressive agent that could be used as a potential therapeutic agent for autoimmune diseases.

More Information Supplier Page